Zepbound works for OSA by helping to reduce excess body weight ... later studies found that this weight loss can help treat sleep apnea that is linked with obesity. Zepbound can be an effective ...

Two studies of 469 adults where participants randomly received either 10 or 15 milligrams of Zepbound or a placebo every week for a year found that ... Zepbound can reduce sleep apnea’s severity ...

WASHINGTON, D.C. — The fight against obstructive sleep apnea ... The promise of Zepbound extends even further. By treating both OSA and obesity simultaneously, it may help reduce risks for ...

Tirzepatide, the medication in the weight-loss drug Zepbound and also the diabetes treatment Mounjaro, appeared to reduce the severity of sleep apnea along ... The study found that patients ...

Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...

There is a need to identify patients with obstructive sleep apnea after a weight-loss drug was approved for treatment of the ...

Zepbound (tirzepatide) is a once-a-week injectable weight-loss medication. It helps reduce your appetite by ... has also approved Zepbound to help with sleep apnea in people with obesity.

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

Tirzepatide, found ... Zepbound is approved for weight loss in adults with a BMI of 30 or higher if they have a related condition like high blood pressure, high cholesterol, Type 2 diabetes, sleep ...

INDIANAPOLIS (dpa-AFX) - The U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea or OSA in adults with obesity ...

Related Aging causes more sleep disruptions, but some tips help Delays in dreaming may be linked to Alzheimer's risk FDA approves weight-loss drug Zepbound to treat sleep apnea "Obstructive sleep ...